Sentences with phrase «lymphoma patients compared»

Larsen will present the study, «Short and Long - Term Risk of Congestive Heart Failure in Breast Cancer and Lymphoma Patients Compared to Controls: an Epidemiologic Study,» on Saturday, March 10.

Not exact matches

«We found very high response rates to this treatment combination, which has the added benefit of having a much reduced risk of long - term organ damage compared to the highly toxic chemotherapy agents typically used for patients with relapsed Hodgkin lymphoma,» says Dr. Kelly, who is Program Director of the Pediatric Hematology / Oncology Service Line at the Women & Children's Hospital of Buffalo and holds an additional faculty appointment with the University at Buffalo.
Patients with a history of breast cancer or lymphoma were more than three times as likely to develop heart failure — a condition in which the heart can't pump enough blood to meet the body's needs — compared with a similar group of patients who did not have cancer, according to data being presented at the American College of Cardiology's 67th Annual Scientific Patients with a history of breast cancer or lymphoma were more than three times as likely to develop heart failure — a condition in which the heart can't pump enough blood to meet the body's needs — compared with a similar group of patients who did not have cancer, according to data being presented at the American College of Cardiology's 67th Annual Scientific patients who did not have cancer, according to data being presented at the American College of Cardiology's 67th Annual Scientific Session.
People with breast cancer or lymphoma were three times as likely to develop heart failure within five years of their cancer diagnosis, and 20 years following cancer treatment were still nearly twice as likely to have been diagnosed with heart failure compared to similar patients who didn't undergo cancer therapy.
Researchers then compared patients in the trial to 151 similar patients who did not have HIV but received the same treatment for their lymphoma using data reported to the Center for International Blood & Marrow Transplant Research (CIBMTR).
However, in this Phase II clinical trial, designed to prospectively evaluate the safety and effectiveness of ACHT for patients with HIV - related lymphoma, researchers discovered that this population had no greater likelihood of developing these complications compared to those without the virus.
CHOP Chemotherapy Plus Rituximab Compared With CHOP Alone In Elderly Patients With Diffuse Large B - Cell Lymphoma
Compared with the United States cancer populations, trials of lymphoma, CLL, CML, and myeloma enrolled a disproportionately higher percentage of patients younger than 65 years.
These patients were significantly underrepresented in trials of new treatments for lymphoma, CLL, and myeloma compared with the incidence of these diseases in that age group.
The use of anti-CD19 chimeric antigen receptor T cells induced a nearly sixfold higher rate of complete response compared with historical outcomes in patients with refractory, aggressive non-Hodgkin lymphoma.
a b c d e f g h i j k l m n o p q r s t u v w x y z